protein kinase C-delta inhibitors (Sapientia Pharmaceuticals)

N/A

Report date: 2025/03/20 10:12:13
NME

Base Information

Drug Nameprotein kinase C-delta inhibitors (Sapientia Pharmaceuticals)
Drug Alias NamePKC-delta inhibitors (Sapientia Pharmaceuticals)protein kinase C-delta inhibitors (BriaCell Therapeutics)PKC-delta inhibitors (BriaCell Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinase C delta inhibitors
TargetsProtein kinase C delta
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSapientia Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesBriaPro Therapeutics Corp
Inactive CompaniesSapientia Pharmaceuticals IncBriacell Therapeutics Corp
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A